Presentation TCT 2013

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

Presenter: David Erlinge, Stefan James, Suman Duvvuru, Joseph Jakubowski, Henrik Wanger, Christoph Varenhorst, Udaya Tantry, Patricia Brown, David Small, Brian Moser, Scott Sundseth, Joseph Walker, Kenneth Winters, Paul Gurbel

January 31, 2013

REGISTER for free or LOG IN to view this content

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

CAD Pharma

Presentation

TCT 2013

Up Next

Presentation TCT 2013

Transcatheter Aortic Valve Implantation with Edwards SAPIEN XT™ versus Medtronic CorEvalve REvalving System® with AccuTrak™: The SAPERE Pilot Study

Presenter: Gill Buchanan

January 31, 2013

Impact of Periprocedural Myocardial Infarction on In-hospital and 2-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Presenter: Seung-Woon Rha

January 31, 2013

Presentation TCT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

October 28, 2013

Advertisement

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

REGISTER for free or LOG IN to view this content

Up Next

Transcatheter Aortic Valve Implantation with Edwards SAPIEN XT™ versus Medtronic CorEvalve REvalving System® with AccuTrak™: The SAPERE Pilot Study

Impact of Periprocedural Myocardial Infarction on In-hospital and 2-year Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

The Valve Medical TAVR System (Israel)

Advertisement

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...

REGISTER for free or LOG IN to view this content

Up Next

We Recommend

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

Point-of-Care Genetic Testing of Eleven CYP2C19 Single Nucleotide Polymorphisms Identifies Extensive and Reduced Metabolizers of Clopidogrel With High Accuracy in Patients With...